Flu clinical trials in Ohio
7 studies for Flu are looking for participants at sites in Ohio.
Cities in Ohio
A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)
- PriMED Clinical Research ( Site 0560), Dayton
- Helios Clinical Research - CLE ( Site 0740), Middleburg Heights
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 13, 2026 · NCT07159763A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Children
- Senders Pediatrics, South Euclid
RecruitingPhase 1Healthy volunteers welcome
Ages 9 to 17 · All sexes · Updated Nov 5, 2026 · NCT07870330Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- The Ohio State University Wexner Medical Center, Columbus
RecruitingPhase 3
28 Days · All sexes · Updated Nov 4, 2026 · NCT02735707Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Columbus
- Research Site, Toledo
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT05624450High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients
- Cincinnati Children's Hospital Medical Center, Cincinnati
RecruitingPhase 2
Ages 3 to 17 · All sexes · Updated Oct 28, 2026 · NCT05947071A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts
- Helios Clinical Research, Inc (former Ventavia Research Group), Middleburg Heights
RecruitingPhase 3
3 Weeks – 11 Years · All sexes · Updated Oct 23, 2026 · NCT06094010A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
- GSK Investigational Site, Blue Ash
- GSK Investigational Site, Cincinnati
- GSK Investigational Site, Columbus
- and 1 more
RecruitingPhase 3Healthy volunteers welcome
Ages 65 and older · All sexes · Updated Sep 18, 2026 · NCT07805707From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.